Monitoring of Busulphan Concentrations in Children Undergone Hematopoietic Stem Cell Transplantation: Unicentric Experience over 10 years.

about

Monitoring of Busulphan Concentrations in Children Undergone Hematopoietic Stem Cell Transplantation: Unicentric Experience over 10 years.

Item

http://www.wikidata.org/entity/Q40085411

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Monitoring of Busulphan Concen ...... tric Experience over 10 years.

@en

type

Item

label

Monitoring of Busulphan Concen ...... tric Experience over 10 years.

@en

prefLabel

Monitoring of Busulphan Concen ...... tric Experience over 10 years.

@en

P1476

Monitoring of Busulphan Concen ...... ntric Experience over 10 years

@en

P2093

Carmine Tinelli

http://www.w3.org/2001/XMLSchema#string

Daniela Di Martino

http://www.w3.org/2001/XMLSchema#string

Edoardo Lanino

http://www.w3.org/2001/XMLSchema#string

Elio Castagnola

http://www.w3.org/2001/XMLSchema#string

Marta Ferretti

http://www.w3.org/2001/XMLSchema#string

Monica Broglia

http://www.w3.org/2001/XMLSchema#string

Stefano Giardino

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatic Veno-Occlusive Disease after Hematopoietic Stem Cell Transplantation: Risk Factors and Stratification, Prophylaxis, and Treatment.

Non-endocrine late complications in children after allogeneic haematopoietic SCT.

Busulfan in infant to adult hematopoietic cell transplant recipients: a population pharmacokinetic model for initial and Bayesian dose personalization.

Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial.

Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee.

An evaluation of engraftment, toxicity and busulfan concentration in children receiving bone marrow transplantation for leukemia or genetic disease.

Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis.

Individualizing high-dose oral busulfan: prospective dose adjustment in a pediatric population undergoing allogeneic stem cell transplantation for advanced hematologic malignancies.

Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantation.

Population pharmacokinetics of oral busulfan in children.

P2888

s13318-017-0431-0

P304

173-181

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13318-017-0431-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Annalisa De Silvestri

Massimiliano Leoni

Antonella L. Bartoli

Maura Faraci

P577

2018-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091159588

http://www.w3.org/2001/XMLSchema#string

P698

28801891

http://www.w3.org/2001/XMLSchema#string